EX-99.1 2 d421219dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

JOINT FILING AGREEMENT

The undersigned hereby agree that a single Schedule 13D (and any amendment thereto) relating to the Common Stock of Compass Therapeutics, Inc. shall be filed on behalf of each of the undersigned and that this Agreement shall be filed as an exhibit to such Schedule 13D.

 

Commander Aggregator, LP
By:  

/s/ James P. Boylan

Name: James P. Boylan
Title: Chief Executive Officer
Enavate Sciences, LP
By: Enavate Sciences GP, LLC
Its: General Partner
By:  

/s/ James P. Boylan

Name: James P. Boylan
Title: Chief Executive Officer
Enavate Sciences GP, LLC
By: Enavate Sciences Holdings, LLC
Its: Sole Member
By:  

/s/ James P. Boylan

Name: James P. Boylan
Title: Chief Executive Officer
Enavate Sciences Holdings, LLC
By:  

/s/ James P. Boylan

Name: James P. Boylan
Title: Chief Executive Officer